Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Symon Gathiaka

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 1, 2013
Design, development and evaluation of novel dual PPARδ/PPARγ agonistsSymon Gathiaka, Gayani Nanayakkara, Tracey Boncher, et al.
Pigment Cell & Melanoma Research|November 29, 2013
Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitorsJaehyuk Choi, Sean F Landrette, Tiffany Wang, et al.
Journal of Computer-Aided Molecular Design|December 6, 2017
D3R Grand Challenge 2: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energiesZied Gaieb, Shuai Liu, Symon Gathiaka, et al.
Journal of Computer-Aided Molecular Design|October 4, 2016
D3R grand challenge 2015: Evaluation of protein-ligand pose and affinity predictionsSymon Gathiaka, Shuai Liu, Michael Chiu, et al.
Communications Biology|July 30, 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionRachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase InhibitorsDerun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-OncologyMin Lu, Hongjun Zhang, Derun Li, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer ImmunotherapyMatthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.
Communications Biology|November 16, 2021
Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionRachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Journal of Medicinal Chemistry|June 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> InhibitorXiaoshen Ma, David L Sloman, Ruchia Duggal, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|January 1, 2013
Design, development and evaluation of novel dual PPARδ/PPARγ agonistsSymon Gathiaka, Gayani Nanayakkara, Tracey Boncher, et al.
Pigment Cell & Melanoma Research|November 29, 2013
Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitorsJaehyuk Choi, Sean F Landrette, Tiffany Wang, et al.
Journal of Computer-Aided Molecular Design|December 6, 2017
D3R Grand Challenge 2: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energiesZied Gaieb, Shuai Liu, Symon Gathiaka, et al.
Journal of Computer-Aided Molecular Design|October 4, 2016
D3R grand challenge 2015: Evaluation of protein-ligand pose and affinity predictionsSymon Gathiaka, Shuai Liu, Michael Chiu, et al.
Communications Biology|July 30, 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionRachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase InhibitorsDerun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-OncologyMin Lu, Hongjun Zhang, Derun Li, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer ImmunotherapyMatthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.
Communications Biology|November 16, 2021
Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionRachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Journal of Medicinal Chemistry|June 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> InhibitorXiaoshen Ma, David L Sloman, Ruchia Duggal, et al.
Pageof 3